Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Steady-state pharmacokinetics of methadone in opioid addicts.

Wolff K, Hay AW, Raistrick D, Calvert R.

Eur J Clin Pharmacol. 1993;44(2):189-94.

PMID:
8453965
2.
3.

Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.

Wolff K, Rostami-Hodjegan A, Hay AW, Raistrick D, Tucker G.

Addiction. 2000 Dec;95(12):1771-83.

PMID:
11177493
4.

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.

Foster DJ, Somogyi AA, White JM, Bochner F.

Br J Clin Pharmacol. 2004 Jun;57(6):742-55.

5.

Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.

de Vos JW, Geerlings PJ, van den Brink W, Ufkes JG, van Wilgenburg H.

Eur J Clin Pharmacol. 1995;48(5):361-6.

PMID:
8641323
6.

Bioavailability and pharmacokinetics of oral and injectable formulations of methadone after intravenous, oral, and intragastric administration in horses.

Linardi RL, Stokes AM, Keowen ML, Barker SA, Hosgood GL, Short CR.

Am J Vet Res. 2012 Feb;73(2):290-5. doi: 10.2460/ajvr.73.2.290.

PMID:
22280392
7.

Pharmacokinetics and pharmacodynamics of methadone enantiomers in hospice patients with cancer pain.

Auret K, Roger Goucke C, Ilett KF, Page-Sharp M, Boyd F, Oh TE.

Ther Drug Monit. 2006 Jun;28(3):359-66.

PMID:
16778720
8.

Stereoselective pharmacokinetics of methadone in chronic pain patients.

Kristensen K, Blemmer T, Angelo HR, Christrup LL, Drenck NE, Rasmussen SN, Sjøgren P.

Ther Drug Monit. 1996 Jun;18(3):221-7.

PMID:
8738759
9.

Pharmacokinetics of methadone during maintenance treatment: adaptive changes during the induction phase.

Nilsson MI, Anggård E, Holmstrand J, Gunne LM.

Eur J Clin Pharmacol. 1982;22(4):343-9.

PMID:
7106170
10.

The pharmacokinetics of methadone in healthy subjects and opiate users.

Wolff K, Rostami-Hodjegan A, Shires S, Hay AW, Feely M, Calvert R, Raistrick D, Tucker GT.

Br J Clin Pharmacol. 1997 Oct;44(4):325-34.

11.

Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence.

Mitchell TB, White JM, Somogyi AA, Bochner F.

Drug Alcohol Depend. 2003 Oct 24;72(1):85-94.

PMID:
14563546
12.

The pharmacokinetics of methadone in adolescents undergoing posterior spinal fusion.

Stemland CJ, Witte J, Colquhoun DA, Durieux ME, Langman LJ, Balireddy R, Thammishetti S, Abel MF, Anderson BJ.

Paediatr Anaesth. 2013 Jan;23(1):51-7. doi: 10.1111/pan.12021. Epub 2012 Sep 14.

PMID:
22978825
13.
14.

The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.

Kukanich B, Lascelles BD, Aman AM, Mealey KL, Papich MG.

J Vet Pharmacol Ther. 2005 Oct;28(5):461-6.

PMID:
16207309
15.

Pharmacokinetic interaction between voriconazole and methadone at steady state in patients on methadone therapy.

Liu P, Foster G, Labadie R, Somoza E, Sharma A.

Antimicrob Agents Chemother. 2007 Jan;51(1):110-8. Epub 2006 Oct 30.

16.

Pharmacokinetics of a new immediate-release methadone tablet formulation with decreased in vitro solubility.

Vinson RK.

Clin Drug Investig. 2012 Jul 1;32(7):487-95. doi: 10.2165/11633550-000000000-00000.

PMID:
22621465
17.

Population pharmacokinetics of methadone hydrochloride after a single intramuscular administration in adult Japanese sika deer (Cervus nippon nippon).

Scala C, Marsot A, Limoges MJ, Locatelli Y, Simon N, Alvarez JC.

Vet Anaesth Analg. 2015 Mar;42(2):165-72. doi: 10.1111/vaa.12186. Epub 2014 Jun 25.

PMID:
24962270
18.

Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.

Meresaar U, Nilsson MI, Holmstrand J, Anggård E.

Eur J Clin Pharmacol. 1981;20(6):473-8.

PMID:
7286059
19.

Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.

Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC.

Int J Clin Pharmacol Ther. 2002 May;40(5):198-206.

PMID:
12051571
20.

Alterations in methadone metabolism during late pregnancy.

Jarvis MA, Wu-Pong S, Kniseley JS, Schnoll SH.

J Addict Dis. 1999;18(4):51-61.

PMID:
10631963

Supplemental Content

Support Center